Skip to main content
Journal cover image

How Low Can We Go-and Should We? Risk Reduction for Minimal-Volume DCIS.

Publication ,  Journal Article
Ryser, MD; Horton, JK; Hwang, ES
Published in: Ann Surg Oncol
February 2018

Duke Scholars

Published In

Ann Surg Oncol

DOI

EISSN

1534-4681

Publication Date

February 2018

Volume

25

Issue

2

Start / End Page

354 / 355

Location

United States

Related Subject Headings

  • Risk Reduction Behavior
  • Prognosis
  • Oncology & Carcinogenesis
  • Mastectomy, Segmental
  • Humans
  • Female
  • Carcinoma, Intraductal, Noninfiltrating
  • Breast Neoplasms
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ryser, M. D., Horton, J. K., & Hwang, E. S. (2018). How Low Can We Go-and Should We? Risk Reduction for Minimal-Volume DCIS. Ann Surg Oncol, 25(2), 354–355. https://doi.org/10.1245/s10434-017-6128-4
Ryser, Marc D., Janet K. Horton, and E Shelley Hwang. “How Low Can We Go-and Should We? Risk Reduction for Minimal-Volume DCIS.Ann Surg Oncol 25, no. 2 (February 2018): 354–55. https://doi.org/10.1245/s10434-017-6128-4.
Ryser MD, Horton JK, Hwang ES. How Low Can We Go-and Should We? Risk Reduction for Minimal-Volume DCIS. Ann Surg Oncol. 2018 Feb;25(2):354–5.
Ryser, Marc D., et al. “How Low Can We Go-and Should We? Risk Reduction for Minimal-Volume DCIS.Ann Surg Oncol, vol. 25, no. 2, Feb. 2018, pp. 354–55. Pubmed, doi:10.1245/s10434-017-6128-4.
Ryser MD, Horton JK, Hwang ES. How Low Can We Go-and Should We? Risk Reduction for Minimal-Volume DCIS. Ann Surg Oncol. 2018 Feb;25(2):354–355.
Journal cover image

Published In

Ann Surg Oncol

DOI

EISSN

1534-4681

Publication Date

February 2018

Volume

25

Issue

2

Start / End Page

354 / 355

Location

United States

Related Subject Headings

  • Risk Reduction Behavior
  • Prognosis
  • Oncology & Carcinogenesis
  • Mastectomy, Segmental
  • Humans
  • Female
  • Carcinoma, Intraductal, Noninfiltrating
  • Breast Neoplasms
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis